SANOFI SAYS NO INTENTION OF BUYING BIOTECH IMCLONE

Sanofi-Aventis does not intend to buy U.S. biotechnology company ImClone Systems Inc, the French drugmaker said on Wednesday. MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=OBR&Date=20061011&ID=6093107)